Publications by the researcher in collaboration with Juan Miguel Ruiz Nodar (11)

2022

  1. Current trends on antithrombotic therapy

    REC: CardioClinics

2020

  1. Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 73, Núm. 9, pp. 749-757

2018

  1. Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU

    Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564

2016

  1. On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013

    Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 551-553

2013

  1. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

    Age and Ageing, Vol. 42, Núm. 1, pp. 70-75

2012

  1. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?

    Circulation: Cardiovascular Interventions, Vol. 5, Núm. 4, pp. 459-466

2011

  1. An evaluation of the CHADS2 stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization

    Chest, Vol. 139, Núm. 6, pp. 1402-1409

2010

  1. The prognostic value of biomarkers after a premature myocardial infarction

    International Journal of Cardiology, Vol. 143, Núm. 3, pp. 249-254

2009

  1. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation

    European Heart Journal, Vol. 30, Núm. 8, pp. 932-939

  2. Premature coronary artery disease in young (age < 45) subjects: Interactions of lipid profile, thrombophilic and haemostatic markers

    International Journal of Cardiology, Vol. 136, Núm. 2, pp. 222-225

2002

  1. Prothrombin fragment F1 + 2 and von Willebrand factor levels and left ventricular systolic function. Peripheral versus intracardiac blood samples [8]

    International Journal of Cardiology